Founders Financial Securities’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.48M | Sell |
19,290
-303
| -2% | -$35.5K | 0.13% | 157 |
|
|
2026
Q1 | $2.4M | Sell |
19,593
-264
| -1% | -$30.5K | 0.14% | 147 |
|
|
2025
Q4 | $2.09M | Sell |
19,857
-16,726
| -46% | -$1.57M | 0.12% | 164 |
|
|
2025
Q3 | $3.07M | Buy |
36,583
+351
| +1% | +$28.9K | 0.21% | 93 |
|
|
2025
Q2 | $2.87M | Buy |
36,232
+13,232
| +58% | +$1.05M | 0.22% | 95 |
|
|
2025
Q1 | $1.91M | Buy |
23,000
+4,014
| +21% | +$375K | 0.16% | 130 |
|
|
2024
Q4 | $1.89M | Buy |
18,986
+1,639
| +9% | +$169K | 0.17% | 115 |
|
|
2024
Q3 | $1.97M | Sell |
17,347
-1,907
| -10% | -$227K | 0.18% | 111 |
|
|
2024
Q2 | $2.38M | Buy |
19,254
+3,452
| +22% | +$445K | 0.23% | 89 |
|
|
2024
Q1 | $2.09M | Buy |
15,802
+450
| +3% | +$55.5K | 0.22% | 93 |
|
|
2023
Q4 | $1.67M | Buy |
15,352
+140
| +0.9% | +$14.5K | 0.19% | 105 |
|
|
2023
Q3 | $1.57M | Buy |
15,212
+934
| +7% | +$101K | 0.2% | 93 |
|
|
2023
Q2 | $1.65M | Buy |
14,278
+263
| +2% | +$29.9K | 0.22% | 91 |
|
|
2023
Q1 | $1.49M | Sell |
14,015
-27
| -0.2% | -$2.92K | 0.22% | 91 |
|
|
2022
Q4 | $1.56M | Buy |
14,042
+1,075
| +8% | +$110K | 0.25% | 87 |
|
|
2022
Q3 | $1.12M | Sell |
12,967
-322
| -2% | -$28.7K | 0.2% | 104 |
|
|
2022
Q2 | $1.21M | Buy |
13,289
+1,308
| +11% | +$116K | 0.24% | 86 |
|
|
2022
Q1 | $983K | Buy |
11,981
+809
| +7% | +$63.8K | 0.17% | 117 |
|
|
2021
Q4 | $856K | Buy |
11,172
+282
| +3% | +$22.5K | 0.15% | 119 |
|
|
2021
Q3 | $818K | Buy |
10,890
+360
| +3% | +$27.4K | 0.16% | 118 |
|
|
2021
Q2 | $819K | Buy |
10,530
+161
| +2% | +$12K | 0.16% | 131 |
|
|
2021
Q1 | $763K | Buy |
10,369
+1,739
| +20% | +$128K | 0.18% | 119 |
|
|
2020
Q4 | $674K | Buy |
8,630
+2,689
| +45% | +$206K | 0.16% | 106 |
|
|
2020
Q3 | $470K | Sell |
5,941
-2,291
| -28% | -$179K | 0.15% | 95 |
|
|
2020
Q2 | $616K | Buy |
8,232
+4,283
| +108% | +$322K | 0.2% | 90 |
|
|
2020
Q1 | $290K | Buy |
3,949
+565
| +17% | +$44.4K | 0.11% | 97 |
|
|
2019
Q4 | $294K | Buy |
3,384
+724
| +27% | +$59.5K | 0.1% | 104 |
|
|
2019
Q3 | $214K | Buy |
+2,660
| New | +$213K | 0.07% | 124 |
|
|
2018
Q4 | – | Sell |
-16,069
| Closed | -$1.09M | – | 110 |
|
|
2018
Q3 | $1.09M | Buy |
16,069
+146
| +0.9% | +$9.3K | 0.3% | 45 |
|
|
2018
Q2 | $922K | Sell |
15,923
-140
| -0.9% | -$7.9K | 0.28% | 55 |
|
|
2018
Q1 | $835K | Buy |
16,063
+362
| +2% | +$19.6K | 0.27% | 58 |
|
|
2017
Q4 | $843K | Buy |
15,701
+2,911
| +23% | +$161K | 0.28% | 52 |
|
|
2017
Q3 | $781K | Buy |
12,790
+573
| +5% | +$34.7K | 0.28% | 54 |
|
|
2017
Q2 | $747K | Buy |
+12,217
| New | +$744K | 0.28% | 54 |
|
Other funds holding MRK
ECSS
Founders Financial Securities's MRK Position: Q2 2026 in Review
Founders Financial Securities reduced its Merck (MRK) stake by 1.5% in Q2 2026, selling an estimated $35.5K and leaving 19,290 shares worth $2.48M. The position accounts for 0.13% of the portfolio, ranked #157.
Founders Financial Securities first reported a position in MRK in Q2 2017 and has held it in 34 quarters since. The position peaked at $3.07M in Q3 2025. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Founders Financial Securities held 19,290 shares of Merck worth $2.48M as of Q2 2026.
- Founders Financial Securities sold 303 Merck shares in Q2 2026, an estimated $35.5K.
- Merck made up 0.13% of Founders Financial Securities's portfolio in Q2 2026, its #157 holding.
- Founders Financial Securities first reported a position in Merck in Q2 2017 and has held it in 34 quarters since.
- Founders Financial Securities's Merck position peaked at $3.07M in Q3 2025.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Founders Financial Securities's 13F filing for Q2 2026, filed 31 Jul 2026.